State Street SPDR S&P U.S. Health Care Select Sect UCITS ETF (LON:GXLV)

London · Delayed Price · Currency is GBP

39.90

+0.52 (1.31%)

Last updated: Sep 22, 2026, 4:00 PM GMT

Assets	410.31M
Expense Ratio	0.15%
PE Ratio	24.77
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a
1-Year Return	+27.82%

Volume	249
Open	39.41
Previous Close	39.39
Day's Range	39.41 - 39.90
52-Week Low	30.91
52-Week High	40.06
Beta	n/a
Holdings	63
Inception Date	Jul 7, 2015

About GXLV

SSgA SPDR ETFs Europe II Public Limited Company - State Street SPDR S&P U.S. Health Care Select Sect UCITS ETF is an exchange traded fund launched and managed by State Street Global Advisors Limited. It is co-managed by State Street Global Advisors, Inc. The fund invests in the public equity markets of the United States. It seeks to invest in the stocks of companies operating in the health care sector. The fund invests in the stocks of large-cap companies. It seeks to replicate the performance of the S&P Health Care Select Sector Index, by investing in the stocks of companies as per their weightings in the index. SSgA SPDR ETFs Europe II Public Limited Company - State Street SPDR S&P U.S. Health Care Select Sect UCITS ETF was formed on July 7, 2015 and is domiciled in Ireland.

Asset Class Equity

Category Health Care

Region North America

Stock Exchange London Stock Exchange

Ticker Symbol GXLV

Provider SPDR

Index Tracked S&P Health Care Select Sector Daily Capped 35/20 Index

Performance

GXLV had a total return of 27.82% in the past year, including dividends. Since the fund's inception, the average annual return has been 5.96%.

Top 10 Holdings

60.51% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	14.87%
Johnson & Johnson	JNJ	10.40%
AbbVie Inc.	ABBV	7.36%
Merck & Co., Inc.	MRK	5.93%
UnitedHealth Group Incorporated	UNH	5.75%
Amgen Inc.	AMGN	3.77%
Thermo Fisher Scientific Inc.	TMO	3.73%
Abbott Laboratories	ABT	3.12%
Gilead Sciences, Inc.	GILD	2.95%
Pfizer Inc.	PFE	2.64%

View More Holdings